HomePDSB • NASDAQ
add
PDS Biotechnology Corp
Previous close
$1.36
Day range
$1.14 - $1.40
Year range
$0.51 - $1.92
Market cap
71.44M USD
Avg Volume
795.96K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.67M | -9.32% |
Net income | -7.56M | 4.90% |
Net profit margin | — | — |
Earnings per share | -0.14 | 33.33% |
EBITDA | -6.66M | 9.34% |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 26.71M | -35.93% |
Total assets | 30.49M | -32.77% |
Total liabilities | 21.24M | -19.40% |
Total equity | 9.25M | — |
Shares outstanding | 55.82M | — |
Price to book | 8.00 | — |
Return on assets | -51.19% | — |
Return on capital | -62.27% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -7.56M | 4.90% |
Cash from operations | -3.70M | 55.04% |
Cash from investing | — | — |
Cash from financing | 4.22M | 2,340.07% |
Net change in cash | 513.32K | 106.37% |
Free cash flow | -6.24M | -6.95% |
About
Founded
2005
Website
Employees
21
